Login
Home
Charts
Search
Watchlist
Products

Mardia Samyoung Capillary Tubes Company Ltd

MSCTC·BSE
57.44-2.00%Wed, 23 Sept '26

Mardia Samyoung Capillary Tubes Company Ltd

MSCTC
BSE
57.44
-2.00%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
456Cr
Close
Close Price
57.44
Industry
Industry
Trading
PE
Price To Earnings
26.47
PS
Price To Sales
4.62
Revenue
Revenue
99Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM
299.43%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000126125
Growth YoY
Revenue Growth YoY%
-100.0
Expenses
ExpensesCr
000010000105923
Operating Profit
Operating ProfitCr
0000-10000221
OPM
OPM%
-141.74.915.43.05.7
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0000-10000221
Tax
TaxCr
000000000110
PAT
PATCr
0000-10000111
Growth YoY
PAT Growth YoY%
-1,100.0-1,450.0-1,700.0-3,475.058.383.9-27.8101.42,680.02,400.0556.5
NPM
NPM%
-150.04.910.41.94.2
EPS
EPS
-0.10.0-0.4-0.3-2.0-0.1-0.1-0.30.01.90.20.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000126125
Growth YoY
Revenue Growth YoY%
-100.0
Expenses
ExpensesCr
000010000105923
Operating Profit
Operating ProfitCr
0000-10000221
OPM
OPM%
-141.74.915.43.05.7
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0000-10000221
Tax
TaxCr
000000000110
PAT
PATCr
0000-10000111
Growth YoY
PAT Growth YoY%
-1,100.0-1,450.0-1,700.0-3,475.058.383.9-27.8101.42,680.02,400.0556.5
NPM
NPM%
-150.04.910.41.94.2
EPS
EPS
-0.10.0-0.4-0.3-2.0-0.1-0.1-0.30.01.90.20.1

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
00000000007499
Growth
Revenue Growth%
-94.9-100.0
Expenses
ExpensesCr
01000000127094
Operating Profit
Operating ProfitCr
0-1000000-1-235
OPM
OPM%
-16,149.04.75.2
Other Income
Other IncomeCr
000000000300
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00000000-1135
Tax
TaxCr
000000000012
PAT
PATCr
00000000-1124
Growth
PAT Growth%
72.5-31.5-8.029.88.689.8222.6-777.8-124.3335.385.6299.4
NPM
NPM%
-11,282.53.03.6
EPS
EPS
0.0-0.6-0.6-0.4-0.40.00.1-0.3-0.71.70.32.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
00000000007499
Growth
Revenue Growth%
-94.9-100.0
Expenses
ExpensesCr
01000000127094
Operating Profit
Operating ProfitCr
0-1000000-1-235
OPM
OPM%
-16,149.04.75.2
Other Income
Other IncomeCr
000000000300
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00000000-1135
Tax
TaxCr
000000000012
PAT
PATCr
00000000-1124
Growth
PAT Growth%
72.5-31.5-8.029.88.689.8222.6-777.8-124.3335.385.6299.4
NPM
NPM%
-11,282.53.03.6
EPS
EPS
0.0-0.6-0.6-0.4-0.40.00.1-0.3-0.71.70.32.2

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
777777777768
Reserves
ReservesCr
998-2-2-2-2-2-3-122
Current Liabilities
Current LiabilitiesCr
10000001201
Non Current Liabilities
Non Current LiabilitiesCr
22222222100
Total Liabilities
Total LiabilitiesCr
191817888887695
Current Assets
Current AssetsCr
121111222331392
Non Current Assets
Non Current AssetsCr
77655555633
Total Assets
Total AssetsCr
191817888887695
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
777777777768
Reserves
ReservesCr
998-2-2-2-2-2-3-122
Current Liabilities
Current LiabilitiesCr
10000001201
Non Current Liabilities
Non Current LiabilitiesCr
22222222100
Total Liabilities
Total LiabilitiesCr
191817888887695
Current Assets
Current AssetsCr
121111222331392
Non Current Assets
Non Current AssetsCr
77655555633
Total Assets
Total AssetsCr
191817888887695

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
000000000-3-86
Investing Cash Flow
Investing Cash FlowCr
00010000-130
Financing Cash Flow
Financing Cash FlowCr
000000000086
Net Cash Flow
Net Cash FlowCr
00000000-100
Free Cash Flow
Free Cash FlowCr
00000000-10
CFO To PAT
CFO To PAT%
156.1119.351.8108.2-5.5-3.713.30.311.8-211.3-3,849.1
CFO To EBITDA
CFO To EBITDA%
109.173.859.0100.6-4.5-0.4-1.10.210.5162.1-2,456.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
000000000-3-86
Investing Cash Flow
Investing Cash FlowCr
00010000-130
Financing Cash Flow
Financing Cash FlowCr
000000000086
Net Cash Flow
Net Cash FlowCr
00000000-100
Free Cash Flow
Free Cash FlowCr
00000000-10
CFO To PAT
CFO To PAT%
156.1119.351.8108.2-5.5-3.713.30.311.8-211.3-3,849.1
CFO To EBITDA
CFO To EBITDA%
109.173.859.0100.6-4.5-0.4-1.10.210.5162.1-2,456.6

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
22216673456
Price To Earnings
Price To Earnings
5.3301.226.5
Price To Sales
Price To Sales
9.14.6
Price To Book
Price To Book
0.20.21.31.54.77.94.5
EV To EBITDA
EV To EBITDA
-2.9-3.5-3.0-2.9-4.1193.092.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
-136.96.56.5
OPM
OPM%
-16,149.04.75.2
NPM
NPM%
-11,282.53.03.6
ROCE
ROCE%
-2.0-2.5-2.9-5.4-5.2-0.50.7-4.6-9.721.33.93.9
ROE
ROE%
-1.9-2.5-2.9-5.4-5.2-0.50.7-4.6-11.521.32.52.5
ROA
ROA%
-1.5-2.2-2.5-3.8-3.5-0.30.4-2.9-7.520.92.32.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
22216673456
Price To Earnings
Price To Earnings
5.3301.226.5
Price To Sales
Price To Sales
9.14.6
Price To Book
Price To Book
0.20.21.31.54.77.94.5
EV To EBITDA
EV To EBITDA
-2.9-3.5-3.0-2.9-4.1193.092.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
-136.96.56.5
OPM
OPM%
-16,149.04.75.2
NPM
NPM%
-11,282.53.03.6
ROCE
ROCE%
-2.0-2.5-2.9-5.4-5.2-0.50.7-4.6-9.721.33.93.9
ROE
ROE%
-1.9-2.5-2.9-5.4-5.2-0.50.7-4.6-11.521.32.52.5
ROA
ROA%
-1.5-2.2-2.5-3.8-3.5-0.30.4-2.9-7.520.92.32.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Mardia Samyoung Capillary Tubes Company Ltd began in 1992 as an Indo-Korean joint venture making precision copper capillary tubes and brass components for industry, but after its factory fell silent and the founding family sold out in late 2024, it is now a completely different animal - a trading house controlled by a Gujarat-based pulses trader that has dismantled its manufacturing past, sold the machinery, and rewritten its charter to pursue agriculture, precious metals, and e-commerce. The recurring approach is a clean break: the new owners acquire a listed shell, erase the old business, and load it with fresh objects and capital, using the public-company platform as a vehicle for whatever comes next. # Business segments A single operating engine - agricultural commodity trading - sits inside a shell that has been legally re-wired for jewellery, bullion, pest-control products, and online retail, but those remain objects on paper, not businesses with revenue. ## 1. Agricultural commodity trading: the only engine that is actually running **The company buys and sells agricultural produce - an extension of the acquirer's existing pulses-trading business - and by May 2026 it was the sole segment generating revenue.** - **Born from the acquirer's day job** - Torextron Ventures Private Limited, the Gujarat entity that bought 69.4% of the company in December 2024, was already trading pulses, with income of about ₹15.3 crore in FY24. The listed company was steered into the same activity, so the new management is doing what it already knows. - **The legal charter caught up in September 2025** - the Board approved adding objects to the Memorandum of Association to carry on business as agriculturists, farmers, and gardeners; to cultivate, grow, produce, harvest, and deal in agricultural produce, fruits, vegetables, seeds, and organic products; and to set up processing units, subject to shareholder and other approvals. That gave formal cover for what was already underway. - **Consultancy is bolted on as a side offering** - the company can now advise farmers on obtaining finance from institutions like NABARD and on organic production, future price trends, and even hydroponics and aeroponics farming. It is a services wrapper around the core trading relationship. - **The man running it comes from agro-industry** - Managing Director Dhaval Dharmendrabhai Joshi, appointed in February 2025 for five years and also serving as CFO, had been a team leader and marketing hand in agro-industries since April 2020. The business is led by someone who grew up in the trade. ## 2. Jewellery, bullion and precious stones: a permission slip, not a business **The company has given itself the legal right to operate across the entire precious-metals and gems value chain - from cutting rough diamonds to selling finished jewellery online - but there is no evidence of any activity yet.** - **The objects clause reads like a directory of the trade** - in September 2025 the Board approved adding main objects to act as goldsmiths, silversmiths, jewellers, gem and diamond merchants, and to manufacture, process, cut, polish, grade, import, export, and deal in every conceivable precious and semi-precious stone, from diamonds and rubies to moonstone and amber. It is an exhaustive list designed to leave no future move off-limits. - **E-commerce is baked in from the start** - the objects authorise online shopping, e-retail trading, net marketing, multi-level marketing, virtual malls, and secured payment processing for business-to-business and business-to-consumer transactions in jewellery, watches, sunglasses, and other consumer goods. The company wants the option to sell direct to consumers through digital channels. - **No revenue, no operations, no timeline** - the filings describe objects and authorisations, not a live business. The segment exists as a legal and strategic option, funded by the capital raised through warrant conversions in early 2026, but it has not yet translated into buying or selling a single gram of gold. ## 3. Public health and agricultural products: a small bet on pest control and sprayers **Alongside the jewellery push, the company added objects to manufacture pest-control products and agricultural sprayers - a narrow industrial sideline that connects to its farming ambitions.** - **Two specific manufacturing lines were authorised** - the Board approved objects to carry on business as manufacturers of public health products for pest control and general insect control, and as manufacturers of all kinds of sprayers for agricultural purposes. It is a targeted addition, not a broad chemical or engineering play. - **It piggybacks on the agricultural trading story** - the same September 2025 board resolution that expanded the company into farming, organic produce, and agricultural consultancy also added these manufacturing objects. The logic appears to be that a company trading in agricultural produce might also sell the tools and products farmers use. # Group structure and partners **The company is a listed shell that changed hands from one promoter group to another in a single transaction, then raised capital by issuing warrants to a roster of individual investors - there is no operating group, just a controlling entity and a widened shareholder base.** - **The Mardia family exited completely** - fourteen selling promoter shareholders, including several Mardia-family individuals, HUFs, and private limited companies with interests in finance, leasing, and trading, sold their entire 69.41% stake to Torextron Ventures Private Limited in December 2024 at ₹5 per share and walked away. - **Torextron Ventures is the new controlling entity** - a Gujarat-registered private company (CIN U51909GJ2021PTC120004) that trades pulses, owned 60.4% by Dhaval Joshi and 39.6% by Keyur Saxsena, with no property, plant, or equipment on its books as of November 2024. Post-acquisition it held 69.42% of the listed company, and after converting warrants in February 2026 its holding rose to about 1.79 crore shares. - **Sixteen non-promoter investors bought warrants in early 2026** - between February 4 and February 6, 2026, the company allotted 7.25 crore fully convertible equity warrants at ₹13.50 apiece to individuals, and by mid-February substantially all had been converted into equity, pushing the paid-up capital from roughly ₹6.9 crore to about ₹67.7 crore. The allottees are a diverse set of individual investors with no disclosed operational role. - **The Korean connection is a historical echo** - the "Samyoung" in the company's name points to a technical collaboration or joint venture with a Korean partner at its 1992 founding, but the current status and details of that relationship are not disclosed in any available filing.

Documents — Mardia Samyoung Capillary Tubes Company Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/4y6kgjkbgb1f9p32t7b5pumc.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/k9377i5jab33fsy3or4ny3ic.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/quiil3n7j6jcesx0fd2v0308.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/bllnpm7ahv0mj5e6c0uemuje.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/pp00duny0lsmgdcvozgdhox6.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/yphvvvcl3cvzaetfo0vbnadt.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/4f66vzvzntnv7ymti01conrv.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/5m25y1zhkjwlmbbq85fxmu8y.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/3zxwcpafc8ywnlam7pui8xtn.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/7tmpx9pqnxdgxo05owid8nm7.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/u4rnbztxytu2mw5bz5fwe81u.pdf